What’s the right way to regulate edited-plants? The question still waits for an answer in Brussels, and debate goes on in Europe.
According to Reuters, France backs non-GMO regulation for crop gene-editing in the EU. Gene editing of crops and livestock may soon be permitted in England, says the Guardian. Parliamentary commissions divided on new breeding techniques, media report in Italy. For a comparative viewpoint of regulatory frameworks globally, see the recent “Genome editing for crop improvement” by All European Academies.
Look at this map, from a detailed and up-to-date analysis published in the CRISPR Journal. It’s the global policy landscape on heritable human editing, i.e., modified embryos transferred to a uterus to initiate a pregnancy. Who would expect a catholic country like Italy to stand out as one of the very few countries not totally prohibiting such a controversial practice?
The research institute CREA is experimenting with CRISPR to improve Italian typical products. The project called BIOTECH is funded with 6 million euros from the Italian ministry of agriculture. Wheat, tomatoes, vines, fruits and more are on the menu, as reported by me in a 6-pages feature published in Le Scienze, the national edition of Scientific American. Continue reading →
It won’t be a candy bar like the one in the picture, but it will be the first CRISPR snack ever eaten in Italy and among the first in the world. A taste of rice edited in Milan, according to rumors. The initiative, organized by The Luca Coscioni Association for freedom of scientific research, will take place on September 18 at 10 am, in front of the Italian Parliament. The first CRISPR meal ever served was a tête-à-tête between a scientist and a journalist in Sweden in September 2016. A month later Calyxt hosted a dinner made with food edited with a different biotech tool in a famous restaurant in Manhattan. The Italian snack is different, however, because of its public nature and political aim. It’s a call to politicians, journalists and scientists to engage in the regulatory debate about genome editing after the EU Court of Justice ruled that edited plants are GMOs. GM field trials are banned in Italy and CRISPR represents a much-needed second chance for geneticists to get out of the impasse.